dc.contributor.author | Karakucuk, Alptug | |
dc.contributor.author | Tashan, Emine | |
dc.contributor.author | Ozturk, Naile | |
dc.contributor.author | Celebi, Nevin | |
dc.date.accessioned | 2022-09-09T07:27:20Z | |
dc.date.available | 2022-09-09T07:27:20Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1304-530X | en_US |
dc.identifier.uri | https://cms.galenos.com.tr/Uploads/Article_39816/TJPS-18-223-En.pdf | |
dc.identifier.uri | http://hdl.handle.net/11727/7635 | |
dc.description.abstract | Objectives: The current study focused on the evaluation of the cytotoxic effect and permeability of ziprasidone hydrochloride monohydrate (ZHM) nanocrystals on Caco-2 cells.
Materials and Methods: ZHM nanocrystals were prepared by the microfluidization method in the presence of polyvinylpyrrolidone as a stabilizer. Particle size (PS), particle size distribution (PDI), and zeta potential (ZP) values were measured in characterization studies. In vitro cytotoxic effects of ZHM nanocrystals were investigated using the 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test. Caco-2 transport studies were conducted with formulations of ZHM coarse powder and nanocrystals.
Results: Nanocrystals were obtained with 400-600 nm PS, 0.1-0.4 PDI, and >20 mV ZP values. The cell viability remained 100% for all sample groups. The permeability value of ZHM nanocrystals through Caco-2 cells increased 2.3-fold in comparison with ZHM coarse powder. Cumulative drug transport also increased at the end of the sampling period.
Conclusion: Nanocrystal technology helps to increase the permeability of drug particles by increasing the saturation solubility. | en_US |
dc.language.iso | eng | en_US |
dc.relation.isversionof | 10.4274/tjps.galenos.2020.67366 | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Caco-2 cells | en_US |
dc.subject | permeability | en_US |
dc.subject | ziprasidone | en_US |
dc.subject | nanocrystal | en_US |
dc.title | In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals | en_US |
dc.type | article | en_US |
dc.relation.journal | TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES | en_US |
dc.identifier.volume | 18 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 223 | en_US |
dc.identifier.endpage | 227 | en_US |
dc.identifier.wos | 000647198000014 | en_US |
dc.identifier.scopus | 2-s2.0-85105234645 | en_US |
dc.contributor.pubmedID | 33902264 | en_US |
dc.contributor.orcID | 0000-0002-6402-5042 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | en_US |